{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-008576","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2024-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.126187+00:00","generated_at":"2026-06-05T05:23:54.718388+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"INVO Bioscience sells $344,925 of future receipts for $236,250; net proceeds $225,000","bullets":["Net proceeds of $225,000 from sale of future receipts; total repayment amount is $344,925.","Weekly payments of $13,797 due until purchase price is fully repaid.","Proceeds to be used for working capital and general corporate purposes.","Transaction structured as a purchase and sale of future receipts, not a traditional loan."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-008576","json":"https://secwatch.observer/filing/0001493152-24-008576.json","markdown":"https://secwatch.observer/filing/0001493152-24-008576.md","text":"https://secwatch.observer/filing/0001493152-24-008576.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224008576/0001493152-24-008576-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224008576/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T05:23:54.718388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"524868902d3588000d0d2de4526f8c3d5eaa856c","claim":"INVO Fertility, Inc. incurred debt of $344,925 with Buyer maturing Until the purchase price has been repaid.","evidence_excerpt":"On February 26, 2024, INVO Bioscience, Inc. (the “Company”) finalized an Agreement for the Purchase and Sale of Future Receipts (the “Future Receipts Agreement”) with a buyer (the “Buyer”) under which the Buyer purchased $344,925 of our future sales for a gross purchase price of $236,250.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224008576/0001493152-24-008576-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Principal","value":"$344,925"},{"label":"Counterparty","value":"Buyer"},{"label":"Maturity","value":"Until the purchase price has been repaid"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"4be6aad5dd0fbcc396531af676230866fda594a4","claim":"INVO Fertility, Inc. entered into Agreement for the Purchase and Sale of Future Receipts with Buyer valued at $236,250 (effective 2024-02-26).","evidence_excerpt":"On February 26, 2024, INVO Bioscience, Inc. (the “Company”) finalized an Agreement for the Purchase and Sale of Future Receipts (the “Future Receipts Agreement”) with a buyer (the “Buyer”) under which the Buyer purchased $344,925 of our future sales for a gross purchase price of $236,250.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315224008576/0001493152-24-008576-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Buyer"},{"label":"Value","value":"$236,250"},{"label":"Effective","value":"2024-02-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}